Cigna Group is exploring the sale of its Medicare Advantage business, which provides additional benefits to those covered by federal health insurance, a move that would mark a reversal of its expansion in the sector, Reuters’ David Carnevali reports, citing people familiar with the matter. Cigna, which got into the Medicare Advantage business with its $3.8B acquisition of HealthSpring in 2011, would be backing away at a time the U.S. government is tightening its purse strings in reimbursing health insurers for their services should it go through with the move, the author notes. Cigna is working with an investment bank to evaluate options for its Medicare Advantage business, which could fetch several billions of dollars in a potential divestment, the sources said.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CI:
- Cigna price target raised to $327 from $300 at RBC Capital
- Cigna raises FY23 adjusted EPS view to $24.75 from $24.70, consensus $24.80
- The Cigna Group Reports Strong Third Quarter 2023 Results, Raises 2023 Adjusted EPS, Revenue, and Cash Flow Outlook
- Cigna reports Q3 adjusted EPS $6.77, consensus $6.67
- Notable companies reporting before tomorrow’s open
Questions or Comments about the article? Write to editor@tipranks.com